NCT05881538

Brief Summary

Post-Infectious Bronchiolitis Obliterans (PIBO) is an irreversible obstructive lung disease characterized by subepithelial inflammation and fibrotic narrowing of the bronchioles after lower respiratory tract infection. This disease is diagnosed mainly in children, more frequently before the age of 2 years. Due to symptoms such as dry cough and dyspnea sensation, most of these patients have low levels of physical activity compared to healthy individuals. Physical activity can positively influence oxygen consumption, muscle strength, and quality of life. High levels of oxygen consumption are associated with a lower risk of respiratory disease and hospitalization. High-intensity interval training (HIIT) may be an effective way to improve oxygen consumption, muscle strength, and quality of life in patients with chronic diseases. HIIT has been shown to produce less dyspnea sensation and to be more entertaining in children and adolescents with respiratory disease compared to continuous training. Thus, the investigators propose to perform telematically real-time guided training to reduce travel times and additional costs to patients. Objective: To analyze the effects of a telematically supervised high-intensity intervallic training program on aerobic fitness, as well as functional/clinical outcomes in patients with PIBO. Methods: Randomized controlled trial with two groups. Exercise group: 16-week HIIT training conducted telematically; Control group: will follow the routine physician's recommendations. Patients will be recruited at Vall D'Hebrón University Hospital (Barcelona), Niño Jesús University Hospital (Madrid), and Donostia Universitary Hospital (San Sebastián). Criteria for participation: (I) Diagnosis of PIBO; (II) Clinically stable at the time of the assessments; (III) Age between 6 to 20 years old.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

May 29, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 31, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2024

Completed
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

1.2 years

First QC Date

April 24, 2023

Last Update Submit

December 3, 2024

Conditions

Keywords

High intensity interval trainingPost-infectious bronchiolitis obliteransTelematic programCardiorespiratory fitness

Outcome Measures

Primary Outcomes (4)

  • Change in peak oxygen consumption

    Change in peak oxygen consumption (mL/kg/min) will be evaluated through cardiopulmonary exercise testing (CPET).

    Change from baseline to 16 weeks

  • Change in time to ventilatory threshold

    Change in time to ventilatory threshold (minutes) will be evaluated through cardiopulmonary exercise testing (CPET).

    Change from baseline to 16 weeks

  • Change in percent oxygen consumption at ventilatory threshold

    Change in percent oxygen consumption at ventilatory threshold will be evaluated through cardiopulmonary exercise testing (CPET).

    Change from baseline to 16 weeks

  • Change in ventilatory efficiency

    Change in ventilatory efficiency will be evaluated by combining ventilation (VE) and carbon dioxide production (VCO2) measurements to report VE/VCO2 ratio, evaluated through cardiopulmonary exercise testing (CPET).

    Change from baseline to 16 weeks

Secondary Outcomes (11)

  • Change in forced expiratory volume in the first second

    Change from baseline to 16 weeks

  • Change in forced vital capacity

    Change from baseline to 16 weeks

  • Change in forced expiratory flow between 25 and 75% of forced vital capacity

    Change from baseline to 16 weeks

  • Change in muscle strength

    Change from baseline to 16 weeks

  • Change in lower body strength

    Change from baseline to 16 weeks

  • +6 more secondary outcomes

Other Outcomes (3)

  • Height in meters

    Change from baseline to 16 weeks

  • Weight in kilograms

    Change from baseline to 16 weeks

  • Daily physical activity level

    Change from baseline to 16 weeks

Study Arms (2)

Exercise group

EXPERIMENTAL

16 weeks of a "High Intensity Interval Training" exercise program conducted telematically with real time supervision twice a week. The exercise program consists of a circuit of exercises aiming to achieve a target heart rate for each fitness level.

Other: Exercise group

Control group

NO INTERVENTION

Routine physician recommendations for physical activity.

Interventions

Participants will perform a 16-week High Intensity Interval Training exercise program, twice a week. The intervention will be conducted telematically with real time supervision.

Also known as: High Intensity Interval Training
Exercise group

Eligibility Criteria

Age6 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of Postinfectious bronchiolitis obliterans;
  • Clinical stability at the time of the assessments;
  • Age between 6 and 20 years old.

You may not qualify if:

  • Symptoms of pulmonary exacerbation during the last four weeks;
  • Diagnosis of other cardiorespiratory diseases leading to symptoms of persistent respiratory dysfunction;
  • Difficulty in comprehension or musculoskeletal alterations that may influence the assessments;
  • Pregnancy;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hospital Universitario Donostia

Donostia / San Sebastian, Basque Country, 20014, Spain

Location

Hospital Universitari Vall d'Hebron

Barcelona, Catalonia, 08035, Spain

Location

Hospital Universitario Infantil Niño Jesús

Madrid, 28009, Spain

Location

MeSH Terms

Conditions

Bronchiolitis Obliterans

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

BronchiolitisBronchitisBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Márcio VF Donadio, PhD

    Universitat Internacional de Catalunya

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The evaluators and care providers will be masked to the allocation of the patients. Given the nature of the intervention, it is not possible to mask patients or monitors in charge of supervising the execution of the exercise training.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Multicenter study, randomized controlled trial in two parallel groups (ratio 1:1), double blinded.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 24, 2023

First Posted

May 31, 2023

Study Start

May 29, 2023

Primary Completion

July 29, 2024

Study Completion

July 29, 2024

Last Updated

December 6, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

The investigators will collect patients' personal data and clinical history by means of the information delivered by the participating hospital. These data will be stored and coded in an Excel file in order to protect confidentiality before, during and after the study. All information will be entered and stored electronically in the institutional platform REDCAP hosted on the hospitals' server.

Time Frame
After completion of study, the data will be stored for as long as necessary to meet any possible responsibilities derived from the study.
Access Criteria
Access will be given only to the researchers of the study.

Locations